Vasella Bowed to Pressure on Pay Agreement: Kulhoff

Play

Feb. 19 (Bloomberg) -- Birgit Kulhoff, analyst at Rahn & Bodmer Banquiers, discusses the agreement between Novartis and outgoing Chairman Daniel Vasella to cancel a non-compete deal that would have paid him $78 million over six years. She speaks on Bloomberg Television's "The Pulse."